title: Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists: With Great Power Comes Great Responsibility.
authors.affiliation: From Division of Nephrology, Department of Medicine (D.Z.I.C.) and Peter Munk Cardiac Centre (J.A.U.), Toronto General Hospital, Toronto, ON, Canada; Department of Physiology, Banting and Best Diabetes Centre (D.Z.I.C.) and Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, Department of Medicine (D.Z.I.C., J.A.U.), University of Toronto, Toronto, ON, Canada; and Women's College Research Institute and Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, ON, Canada (J.A.U.).
authors.forename: David Z I
authors.initials: DZ
authors.lastname: Cherney
authors.affiliation: From Division of Nephrology, Department of Medicine (D.Z.I.C.) and Peter Munk Cardiac Centre (J.A.U.), Toronto General Hospital, Toronto, ON, Canada; Department of Physiology, Banting and Best Diabetes Centre (D.Z.I.C.) and Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, Department of Medicine (D.Z.I.C., J.A.U.), University of Toronto, Toronto, ON, Canada; and Women's College Research Institute and Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, ON, Canada (J.A.U.). jay.udell@utoronto.ca.
authors.forename: Jacob A
authors.initials: JA
authors.lastname: Udell
mesh_terms: D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D000072096:Cardiologists; D000066491:Clinical Decision-Making; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D005960:Glucosides / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018579:Patient Selection; D012307:Risk Factors; D051297:Sodium-Glucose Transporter 2 / Q000378:metabolism; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D016896:Treatment Outcome
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C570240:empagliflozin
keywords: cardiovascular diseases; diabetes mellitus; heart failure; kidney; prevention and control; sodium-glucose transporter 2